1-3 of 3
Aarti Oza
Close
Sort by
Journal Articles

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

Clinical Trials & Observations
Mark Girgis, Chris Hallemeier, William Blum, Randy Brown, Hsiu-san Lin, Hanna Khoury, L. Tim Goodnough, Ravi Vij, Steve Devine, Marita Wehde, Stacey Postma, Aarti Oza, John DiPersio, Douglas Adkins
Journal: Blood
Blood (2005) 105 (8): 3035–3041.
https://doi.org/10.1182/blood-2003-07-2346
Published: 2005
Journal Articles

Once Daily Ganciclovir (ODG) as Initial Pre-Emptive Therapy (PT) Delayed until Threshold Viral Load ≥10,000 Copies/ml: A Safe and Effective Strategy for Post-Allogeneic Stem Cell Transplant (ASCT) Patients.

Linda A. Verkruyse, MD, Aarti Oza, Steven M. Devine, MD, Douglas R. Adkins, MD, Hanna Khoury, MD, John F. DiPersio, MD, Ravi Vij, MD
Journal: Blood
Blood (2004) 104 (11): 3158.
https://doi.org/10.1182/blood.V104.11.3158.3158
Published: 2004
Journal Articles

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation

Clinical Trials & Observations Brief Report
Ravi Vij, John F. DiPersio, Partha Venkatraman, Kathryn Trinkaus, Lawrence T. Goodnough, Randy A. Brown, Hanna J. Khoury, Steven M. Devine, Aarti Oza, Shalini Shenoy, William Blum, Douglas Adkins
Journal: Blood
Blood (2003) 101 (5): 2067–2069.
https://doi.org/10.1182/blood-2002-07-2110
Published: 2003